View in EDS PDF Full Text

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.

Saved in:
Bibliographic Details
Title: Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.
Authors: Roncolato FT; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia felicia.roncolato@ctc.usyd.edu.au.; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia.; Macarthur Cancer Therapy Centre, New South Wales, Australia., Joly F; Centre Francois Baclesse, Caen, France., O'Connell R; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Lanceley A; University College London, London, England., Hilpert F; Klinik fur Gynakologie und Geburtshilfe, UKSH, Kiel, Germany., Buizen L; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Okamoto A; The Jikei University School of Medicine, Tokyo, Japan., Aotani E; Kitasato Academic Research Organization, Tokyo, Japan., Pignata S; Istituto Nazionale per lo Studio e la Cura dei Tumori - Fondazione G. Pascale, IRCCS, Napoli (MITO), Italy., Donnellan P; Cancer Trials Ireland, Galway University Hospital, Galway, Ireland., Oza A; Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Avall-Lundqvist E; Department of Oncology, Linköping University, Linköping, Sweden.; Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.; Karolinska Institutet, Stockholm, Sweden., Berek JS; Stanford Comprehensive Cancer Institute, Stanford, California, USA., Heitz F; AGO Study group and Department of Gynecology & Gynecologic Oncology, Kliniken Essen Mitte (KEM), Essen, Germany., Feeney A; Cancer Research UK & UCL Cancer Trials Centre, London, England., Berton-Rigaud D; ICO Centre René Gauducheau, Saint Herblain, France., Stockler MR; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia., King M; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia.; Psycho-oncology Research Group (PoCoG), School of Psychology and Sydney Medical School, University of Sydney, Sydney, Australia., Friedlander M; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia.; Prince of Wales Hospital, Sydney, Australia.
Corporate Authors: GCIG Symptom Benefit group
Source: The oncologist [Oncologist] 2017 Sep; Vol. 22 (9), pp. 1117-1124. Date of Electronic Publication: 2017 Jun 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28596446
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Roncolato+FT%22">Roncolato FT</searchLink>; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia felicia.roncolato@ctc.usyd.edu.au.; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia.; Macarthur Cancer Therapy Centre, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Joly+F%22">Joly F</searchLink>; Centre Francois Baclesse, Caen, France.<br /><searchLink fieldCode="AU" term="%22O'Connell+R%22">O'Connell R</searchLink>; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Lanceley+A%22">Lanceley A</searchLink>; University College London, London, England.<br /><searchLink fieldCode="AU" term="%22Hilpert+F%22">Hilpert F</searchLink>; Klinik fur Gynakologie und Geburtshilfe, UKSH, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Buizen+L%22">Buizen L</searchLink>; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Okamoto+A%22">Okamoto A</searchLink>; The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Aotani+E%22">Aotani E</searchLink>; Kitasato Academic Research Organization, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Pignata+S%22">Pignata S</searchLink>; Istituto Nazionale per lo Studio e la Cura dei Tumori - Fondazione G. Pascale, IRCCS, Napoli (MITO), Italy.<br /><searchLink fieldCode="AU" term="%22Donnellan+P%22">Donnellan P</searchLink>; Cancer Trials Ireland, Galway University Hospital, Galway, Ireland.<br /><searchLink fieldCode="AU" term="%22Oza+A%22">Oza A</searchLink>; Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Avall-Lundqvist+E%22">Avall-Lundqvist E</searchLink>; Department of Oncology, Linköping University, Linköping, Sweden.; Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.; Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Berek+JS%22">Berek JS</searchLink>; Stanford Comprehensive Cancer Institute, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Heitz+F%22">Heitz F</searchLink>; AGO Study group and Department of Gynecology & Gynecologic Oncology, Kliniken Essen Mitte (KEM), Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Feeney+A%22">Feeney A</searchLink>; Cancer Research UK & UCL Cancer Trials Centre, London, England.<br /><searchLink fieldCode="AU" term="%22Berton-Rigaud+D%22">Berton-Rigaud D</searchLink>; ICO Centre René Gauducheau, Saint Herblain, France.<br /><searchLink fieldCode="AU" term="%22Stockler+MR%22">Stockler MR</searchLink>; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22King+M%22">King M</searchLink>; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia.; Psycho-oncology Research Group (PoCoG), School of Psychology and Sydney Medical School, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Friedlander+M%22">Friedlander M</searchLink>; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia.; Prince of Wales Hospital, Sydney, Australia.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22GCIG+Symptom+Benefit+group%22">GCIG Symptom Benefit group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2017 Sep; Vol. 22 (9), pp. 1117-1124. <i>Date of Electronic Publication: </i>2017 Jun 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28596446
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1634/theoncologist.2017-0047
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1117
    Titles:
      – TitleFull: Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Roncolato FT
      – PersonEntity:
          Name:
            NameFull: Joly F
      – PersonEntity:
          Name:
            NameFull: O'Connell R
      – PersonEntity:
          Name:
            NameFull: Lanceley A
      – PersonEntity:
          Name:
            NameFull: Hilpert F
      – PersonEntity:
          Name:
            NameFull: Buizen L
      – PersonEntity:
          Name:
            NameFull: Okamoto A
      – PersonEntity:
          Name:
            NameFull: Aotani E
      – PersonEntity:
          Name:
            NameFull: Pignata S
      – PersonEntity:
          Name:
            NameFull: Donnellan P
      – PersonEntity:
          Name:
            NameFull: Oza A
      – PersonEntity:
          Name:
            NameFull: Avall-Lundqvist E
      – PersonEntity:
          Name:
            NameFull: Berek JS
      – PersonEntity:
          Name:
            NameFull: Heitz F
      – PersonEntity:
          Name:
            NameFull: Feeney A
      – PersonEntity:
          Name:
            NameFull: Berton-Rigaud D
      – PersonEntity:
          Name:
            NameFull: Stockler MR
      – PersonEntity:
          Name:
            NameFull: King M
      – PersonEntity:
          Name:
            NameFull: Friedlander M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2017 Sep
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1549-490X
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: The oncologist
              Type: main
ResultId 1